RxDoctor Payments Data

John Morris

Endocrinology, Diabetes & Metabolism · Rochester, MNNPI 1962489070

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $1,500 of the $1,559 with a category attached, or 96.2%. Medtronic accounts for 96.2% of it on its own, with 1 other manufacturer making up the rest.

$1,559in general payments, 2019–2025

Across 3 payments — averaging $519.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Trisalus Life Sciences, Inc.$59
$1,907,729in research payments, 2019–2025

Across 14 payments — averaging $136,266 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$1.9M

What the payments were for

  • Speaking & faculty fees$1,50096%
  • Food & beverage$594%

General payments by program year

22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic1$1,500
Trisalus Life Sciences, Inc.2$59

How this compares

$1,559 in reported general payments places this provider in the 60th percentile of 120 endocrinology, diabetes & metabolism providers in Minnesota.

See all endocrinology, diabetes & metabolism providers in Minnesota

Most prescribed under Part D

DrugClaimsCost to plans & patients
SynthroidLevothyroxine Sodium33$3,575
Levothyroxine Sodium126$1,664

Paid to pharmacies, not to this prescriber.

Other endocrinology, diabetes & metabolism in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →